MedTrace Logo

UCon Treatment of the Symptoms of Faecal Incontinence (FI)

NCT05864807 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-02-18

No results posted yet for this study

Summary

UCon is a medical device for treatment of the symptoms of overactive bladder and fecal incontinence (FI). It electrically stimulates the DGN through the skin to obtain modulated behaviour of the bladder/bowel musculature e.g., suppress undesired bladder/bowel activity to relieve the symptoms of the patient. This clinical investigation is designed as a single-arm, prospective, single-centre, early feasibility study.

Conditions

  • Faecal Incontinence
  • Faecal Incontinence With Faecal Urgency

Interventions

DEVICE

UCon

The participant self-administer electrical stimulation to the dorsal genital nerve (DGN) for 4 weeks using UCon

Sponsors & Collaborators

  • InnoCon Medical

    lead INDUSTRY

Principal Investigators

  • Eloy Espin Basany, MD · Vall d'Hebron University Hospital, 119, 08035 Barcelona, Spanien

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2026-02-02
Completion
2026-02-02

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05864807 on ClinicalTrials.gov